PYC Therapeutics
Wissam Chiha began working as a Senior Scientist at PYC Therapeutics in January 2020 and continues to hold that role. Prior to this, they completed their PhD at The University of Western Australia, starting in November 2013 and finishing in October 2019.
Wissam Chiha completed a degree in Neuroscience at The University of Western Australia from 2008 to 2010.
This person is not in any offices
PYC Therapeutics
1 followers
PYC Therapeutics is a development-stage biotechnology company pioneering a new generation of RNA therapeutics that utilize Cell Penetrating Peptides (CPPs), a revolutionary delivery technology designed to overcome the major challenges of current gene-based therapies.